LMR Partners’s Caribou Biosciences CRBU Stock Holding History

LMR Partners’s Portfolio CRBU Stock Details CRBU Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2024 Q3	–	Sell	-15,207	Closed	-$24.9K	–	1331
2024 Q2	$24.9K	Hold	15,207	–	–	﹤0.01%	972
2024 Q1	$78.2K	Hold	15,207	–	–	﹤0.01%	941
2023 Q4	$87.1K	Hold	15,207	–	–	﹤0.01%	771
2023 Q3	$72.7K	Hold	15,207	–	–	﹤0.01%	700
2023 Q2	$64.6K	Hold	15,207	–	–	﹤0.01%	648
2023 Q1	$80.7K	Hold	15,207	–	–	﹤0.01%	955
2022 Q4	$95.5K	Hold	15,207	–	–	﹤0.01%	1048
2022 Q3	$160K	Sell	15,207 -79,793	-84%	-$744K	﹤0.01%	1031
2022 Q2	$516K	Buy	95,000 +85,000	+850%	+$650K	0.01%	902
2022 Q1	$92K	Hold	10,000	–	–	﹤0.01%	1189
2021 Q4	$151K	Hold	10,000	–	–	﹤0.01%	1093
2021 Q3	$239K	Buy	+10,000	New	+$244K	﹤0.01%	911

Other funds holding CRBU

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return

PHS

PFM Health Sciences San Francisco, California $1.1B AUM 57.92% 1-Year Est. Return

KCM

Kynam Capital Management Princeton, New Jersey $1.62B AUM 138.67% 1-Year Est. Return

EWM

Elmwood Wealth Management Berkeley, California $400M AUM 17.81% 1-Year Est. Return

Point72 Asset Management Stamford, Connecticut $78.1B AUM 55.25% 1-Year Est. Return

Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

SSA

Schonfeld Strategic Advisors New York $14.2B AUM 37.17% 1-Year Est. Return

LMR Partners's CRBU Position: Q3 2024 in Review

LMR Partners sold out of Caribou Biosciences (CRBU) in Q3 2024, closing a stake of 15,207 shares — an estimated $24.9K sold.

LMR Partners first reported a position in CRBU in Q3 2021 and held it in 12 quarters. The position peaked at $516K in Q2 2022. 129 funds tracked by Wall St. Rank hold CRBU as of Q3 2024.

LMR Partners reported no remaining Caribou Biosciences position as of Q3 2024 after selling out during the quarter.
LMR Partners sold 15,207 Caribou Biosciences shares in Q3 2024, an estimated $24.9K.
LMR Partners first reported a position in Caribou Biosciences in Q3 2021 and held it in 12 quarters.
LMR Partners's Caribou Biosciences position peaked at $516K in Q2 2022.
129 funds tracked by Wall St. Rank held Caribou Biosciences as of Q3 2024.

Based on LMR Partners's 13F filing for Q3 2024, filed 7 Nov 2024.